Jefferies initiated coverage on Krystal Biotech with a new price target
$KRYS
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Jefferies initiated coverage of Krystal Biotech with a rating of Buy and set a new price target of $245.00